Yeah, someone really took a big interest at the close today. I reckon what got the big boys excited was all that "new standard of care" and "assembling a business development team" talk. Got me excited anyway!
Some key information we could look for to push this much higher are: 1. VISION data 2. FDA progress/updates 3. Patent / IP strategy
With a big unknown around NOX-COVID.
But hey, with growing proof that Veyonda is effective on multiple cancers -- boosting radio, chemo and immuno -- why not cure COVID-19 too?! Sometimes I really do wonder if it's too good to be true...
NOX Price at posting:
83.0¢ Sentiment: Buy Disclosure: Held
